Visudyne: Clinical Trials

5 trials of Visudyne, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 11Completed 1

Follow Visudyne: new trials by email Literature Review of Visudyne trials Research Report on Visudyne

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study
Endoscopic Ultrasound, Fluorescence Imaging, Photodynamic Therapy - Advanced Pancreatic Carcinoma, Locally Advanced Pancreatic Carcinoma
Phase 2CompletedMayo Clinic132017-05-312025-07-30
Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy
Verteporfin, ranibizumab - Chronic Central Serous Chorioretinopathy
Phase 1 / Phase 2CompletedJang Won Heo342009-07-012013-05-27
Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)
verteporfin, ranibizumab, dexamethasone - Choroidal Neovascularization, Macular Degeneration
Phase 2CompletedQLT Inc.1622007-07-012011-06-02
Ranibizumab and Reduced Fluence PDT for AMD
ranibizumab, verteporfin - Macular Degeneration
Phase 2CompletedTexas Retina Associates602007-05-012025-11-28
Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration
Visudyne, Kenalog - Age-Related Macular Degeneration
Phase 2CompletedManhattan Eye, Ear & Throat Hospital1062003-10-012007-07-12

Conditions studied

Macular Degeneration (3)  ·  Choroidal Neovascularization (1)  ·  Neovascularization, Pathologic (1)  ·  Pancreatic Neoplasms (1)

Sponsors

Jang Won Heo (1)  ·  Manhattan Eye, Ear & Throat Hospital (1)  ·  Mayo Clinic (1)  ·  QLT Inc. (1)  ·  Texas Retina Associates (1)

Countries

United States (4)  ·  Canada (2)  ·  South Korea (1)

Top investigators

Allen Ho, MD (1)  ·  Andrew Strong, Ph.D (1)  ·  David Callanan, MD (1)  ·  Henry Hudson, MD (1)  ·  Jang Won Heo, Professor (1)  ·  Oscar Cuzzani, MD (1)  ·  Richard F. Spaide, MD (1)  ·  Vinay Chandrasekhara, M.D. (1)

Results publications

PMID 21742303, PMID 33647286, PMID 34261044, PMID 40522203

NIH funding

P01CA084203 (1)